ORY-1001, a potent and selective covalent KDM1A inhibitor, for the treatment of Acute Leukemia (Sample3)
收藏官方服务：
资源简介：
Sample3 THP-1 H3K4me2 ChIPSeq Data after ORY-1001 treatment
应用场景：
创建时间：
2018-03-05
相关数据集
Combined ANA and IDA treatment is an innovative and promising therapeutic strategy for AML patients with high PDE3A expression
Acute myeloid leukemia (AML) is an invasive hematopoietic malignancy requiring novel treatment strategies. The PDE3A inhibitor anagrelide (ANA) profoundly suppresses the proliferation of high PDE3A-ex
NIAID Data Ecosystem120
A STAT5B-CD9 axis determines self-renewal in hematopoietic and leukemic stem cells
The transcription factors STAT5A and STAT5B are critical in hematopoiesis and leukemia. They are widely believed to have redundant functions but we describe a unique role for STAT5B in driving the sel
NIAID Data Ecosystem40
A potent and selective small-molecule degrader of ENL suppresses leukemia progression in vivo (ChIP-Seq)
ENL, a stoichiometric component of the Super Elongation Complex (SEC) as well as the histone H3K79 methyltransferase DOT1L complex, is involved in the regulation of transcription elongation. Loss-of-f
NIAID Data Ecosystem30
Genetic and chemical targeting of the ATPase complex TIP48 and 49 impairs acute myeloid leukemia
The chromatin-associated AAA+ ATPases Tip48 and Tip49 are the core components of various complexes implicated in diverse nuclear events such as DNA repair and gene regulation. Although they are freque
NIAID Data Ecosystem60
Additional file 7 of Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches
Additional file 7: Table S1: Upstream regulators by guadecitabine in all tumor types; Table S2: Enrichment analysis of Upstream regulators up-regulated in GBM vs MM-BM; Table S3: Enrichment analysis o
NIAID Data Ecosystem40
